The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...
Shares of UnitedHealth Group (NYSE: UNH) were pulling back Thursday after the company delivered underwhelming fourth-quarter ...
UnitedHealth's high medical costs and lower-than-expected revenue in the fourth quarter underscored persistent challenges at ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
Overall, analysts tracked by FactSet expect UnitedHealth to post $101.6 billion in revenue, up from $94.4 billion a year prior. Analysts also model $6.73 in adjusted earnings per share, up from $6.16 ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...
Governor Henry McMaster today unveiled his Executive Budget for fiscal year 2025-2026, which prioritizes fiscal responsibility, accelerates income tax cuts, raises teacher pay, and invests in critical ...
In the first of a three-part mini-series, Dr Toni Hazell discusses some key decisions that need to be made when a woman is ...
Wealth Advisors LLC lifted its stake in Humana Inc. (NYSE:HUM – Free Report) by 15.6% in the 4th quarter, according to its ...
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...